SLC7A11 and Alzheimer disease: As shown in the results (Fig. 4C), the levels of SAT1, GPX4, and SLC7A11 in astrocytes of the AD model decreased, while the levels of NOX4, 4-HNE, MDA, FTH1, and ACSL4 increased.